Table 1.
Laboratory characteristics of the patient at the baseline and after 2 months of follow-up
| Investigation | At admission | After 3 months of treatment |
|---|---|---|
| Hemoglobin (g/dL) | 9 | 12 |
| Total leukocyte count (cells per microliter) | 6000 | 5400 |
| Platelets (*103 (cells per microliter) | 130 | 220 |
| Total bilirubin (mg/dL) | 0.44 | 0.5 |
| SGOT (U/L) | 14 | 12 |
| SGPT (U/L) | 39 | 18 |
| ALP (U/L) | 76 | 54 |
| LDH (U/L) | 165 | 120 |
| Total protein (g/dL) | 6.64 | 6.2 |
| Albumin (g/dL) | 2.27 | 3.5 |
| PT/INR | 16.5/1.42 | 12/0.9 |
| Creatinine (mg/dL) | 0.93 | 0.82 |
| Serum HCO3- (mEq/L) | 25 | |
| C3 (mg/L) (970-1576) | 1384 | - |
| C4 (mg/L) (162-445) Viral serology: | 191 | - |
| Anti HAV | Negative | |
| Anti HEV | Negative | |
| HBsAg | Negative | |
| Anti HCV | Negative | |
| ANA | Negative | |
| ANCA | Negative | |
| ASMA | Negative | |
| Anti LKM | Negative | |
| 24 h urinary copper (<40) | 250 mcg/day | |
| Serum ceruloplasmin (20-40) | 5.4 mg/dL | |
| Urine routine microscopy | pH-6.7 | RBCs 1-2/HPF |
| 24 h | RBCs/HPF- Numerous RBC casts (+) Protein 2+Glucose negative | Protein (-) |
| Urine protein (g/d) | 1.1 | 0.21 |
| Calcium (100-300) | 138 mg/day | |
| Phosphorous (400-1300) | 565 mg/day |